Overview
From a portfolio lens, Chainlink ($6.30B) and Injective ($490.41M) offer different beta to bitcoin cycles. The overview below keeps the facts first and the narrative second.
Quick winners
Full comparison
| Metric | LINK | INJ |
|---|---|---|
| Price | $8.35 | $5.13 |
| Market Cap | $6.30B | $490.41M |
| FDV | — | — |
| Volume 24h | $9.90M | $2.59M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 19.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +4.13% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | LINK | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +3.90% | +3.91% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | LINK | INJ |
|---|---|---|
| RSI | 45.39 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.33 | 0.29 |
| ADX | 14.96 | 12.19 |
| Support | 8.20 | 4.91 |
| Resistance | 8.73 | 5.47 |
| Trend | neutral | neutral |
| Momentum | — | — |
| Signal | neutral | neutral |
Automatic technical analysis
Relative technical health favors reading both charts side by side. AI scores (47.70 vs 48.70) summarize PEPS modules, but supports and resistances still decide invalidation.
Fundamentals
| Metric | LINK | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 87.00 | 0.00 |
| Github activity | 5,703.00 | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Chainlink
Injective
Pros and cons
Pros of Chainlink
- Chainlink typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Market-cap scale on Chainlink may dampen some idiosyncratic shocks versus smaller peers.
- Chainlink has an established coin page footprint on PEPS for continuous monitoring.
- LINK often anchors narratives that attract sustained media and analyst coverage.
Cons of Chainlink
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Large-cap status for Chainlink can mean slower percentage upside versus high-beta alternatives.
- Indicator stacks on Chainlink may stay stretched longer than expected in strong trends.
Pros of Injective
- If technical momentum aligns, Injective may outperform on medium-term windows.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
Cons of Injective
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Trend failures on Injective often travel faster than on more established assets.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
Which looks stronger right now?
If you weight capitalization and liquidity, Chainlink looks sturdier; if you weight 24h tape, Injective is ahead. A balanced view treats both as incomplete signals.
AI summary
Comparing LINK and INJ begins with structure: capitalization, volume and rank. Present prints are $8.35 versus $5.13. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate INJ-vs-LINK pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, Chainlink or Injective?
“Better” depends on horizon and risk. Chainlink leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, LINK or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Chainlink and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Chainlink currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.